Showing results (91-100 of 192) with videos related to

Sort By:
Pageof 20
BMC Pulmonary Medicine|October 17, 2022
Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective studyJingwen Wei, Jing Xiang, Yue Hao, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Comparison of Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy between B3 Thymoma and Thymic CarcinomaYue Hao, Jinfei Si, Jianan Jin, et al.
Medical Oncology (Northwood, London, England)|December 2, 2022
Efficacy of EGFR-Tyrosine Kinase Inhibitors for advanced non-small cell lung cancer patients harboring rare EGFR mutations of exon 18 E709XYue Hao, Manyi Xu, Huan Zhou, et al.
Clinical Lung Cancer|December 18, 2018
De Novo MET Amplification in Chinese Patients With Non-Small-Cell Lung Cancer and Treatment Efficacy With Crizotinib: A Multicenter Retrospective StudyZhengbo Song, Hong Wang, Zongyang Yu, et al.
Journal of Thoracic Disease|March 13, 2023
Clinical outcomes of immune checkpoint inhibitor therapy for advanced lung adenosquamous carcinomaJingwen Wei, Jing Xiang, Yue Hao, et al.
Investigational New Drugs|December 1, 2024
Efficacy of immune checkpoint inhibitor rechallenge in initial immunotherapy responders with advanced non-small cell lung cancer: A single-center retrospective studyManyi Xu, Yanhua Wang, Ke Wang, et al.
BMC Pulmonary Medicine|May 7, 2022
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective studyWenxian Wang, Lan Shao, Yibing Xu, et al.
Contrast Media & Molecular Imaging|August 1, 2022
The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced ThrombocytopeniaWenxian Wang, Xiaodong Gu, Lan Shao, et al.
Journal of Translational Medicine|February 23, 2019
Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective studyWenxian Wang, Hong Wang, Peihua Lu, et al.
BMC Pulmonary Medicine|May 5, 2023
Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutationsJinfei Si, Yue Hao, Jingwen Wei, et al.
Pageof 20